...
首页> 外文期刊>European journal of anaesthesiology >The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation.
【24h】

The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation.

机译:右美托咪定输注用于镇静接受清醒纤维鼻插管的口腔癌患者的镇静作用。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND AND OBJECTIVE: Dexmedetomidine is characterized with effects of sedation, analgesia, amnesia and lack of respiratory depression. Hence, it should be suitable for awake fibreoptic intubation (AFOI). METHODS: We enrolled 30 oral cancer patients with limited mouth openings who were undergoing AFOI for elective surgery. Patients were randomly allocated into two groups; the Dex group (n = 16) that received dexmedetomidine (1.0 microg kg(-1)) infusion and the Control group (n = 14) that received fentanyl (1.0 microg kg(-1)) infusion. Main outcomes were evaluated by grading scores presenting conditions for nasal intubation and postintubation. Other analysed parameters included airway obstruction, haemodynamic changes, consumption time for intubation, amnesia level and satisfaction. RESULTS: Intubation score (1-5) representing condition for nasal intubation was significantly better in the Dex group [2(1-3)] than in the Control group [3(2-5)] (P = 0.001). Postintubation score (1-3) representing tolerance to intubation also showed more favourable results in the Dex group [1(1-3)] than in the Control group [2(2-3)] (P = 0.002). The Dex group showed significantly reduced haemodynamic response to intubation than the Control group. Incidence requiring temporary haemodynamic support was higher in the Dex group but not of significance. Both levels of amnesia and satisfaction score were significant in the Dex group. Other analysed parameters such as consumption time for intubation, airway obstruction score and postoperative adverse events did not differ significantly. CONCLUSION: Combination of dexmedetomidine loading with topical anaesthesia provides significant benefit for AFOI in intubation condition, patient tolerance, haemodynamic response, amnesia and satisfaction. Dexmedetomidine is effective for AFOI in anticipated difficult airway with only minor and temporary haemodynamic adverse effects.
机译:背景与目的:右美托咪定的特点是镇静,镇痛,健忘和缺乏呼吸抑制作用。因此,它应该适合于清醒的光纤插管(AFOI)。方法:我们招募了30名正在接受AFOI择期手术的口腔张开受限的口腔癌患者。患者被随机分为两组。接受右美托咪定(1.0 microg kg(-1))输注的Dex组(n = 16)和接受芬太尼(1.0 microg kg(-1))输注的对照组(n = 14)。通过对鼻插管和插管后状况进行评分的评分来评估主要结局。其他分析参数包括气道阻塞,血流动力学变化,插管消耗时间,健忘水平和满意度。结果:Dex组[2(1-3)]中代表鼻插管的插管得分(1-5)明显好于对照组[3(2-5)](P = 0.001)。代表插管耐受性的插管后评分(1-3)在Dex组[1(1-3)]中也显示出比对照组[2(2-3)]更有利的结果(P = 0.002)。与对照组相比,Dex组显示出对插管的血流动力学反应明显降低。在Dex组中,需要临时血流动力学支持的发生率较高,但意义不大。敏捷组的健忘和满意度得分均显着。其他分析参数,例如插管消耗时间,气道阻塞评分和术后不良事件没有显着差异。结论:右美托咪定负荷与局部麻醉相结合可在插管状况,患者耐受性,血流动力学反应,健忘和满意度方面为AFOI带来显着益处。右美托咪定在预期的困难气道中对AFOI有效,仅有轻微和暂时的血液动力学不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号